drugset / Trial / NCT07589075
Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation
RandomizedParallel-groupSingle-blindTreatment
Summary
The aim of the study is to assess the efficacy of adjuvant therapy dapagliflozin, metformin as monotherapy and combination of both in comparison to control group in induction of ovulation with letrozole in women PCOS, focusing specifically on rates of ovulation and pregnancy.
Timeline
- Start
- 2023-10-20
- Primary completion
- 2024-07-01
- Completion
- 2025-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 5 mg | Oral |
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
| Background | Letrozole | Other / unclassified | 2.5 mg | Oral |
Indications
No indication recorded.